Skip to main content
TipRanks
Go Ultimate75% OFF

Timothy William Watts Insider Profile

4 Followers

Timothy William Watts, Chief Executive Officer at Shield Therapeutics, holds 1.75M shares in Shield Therapeutics (Ticker: GB:STX), holds 27.57K shares in Fusion Antibodies Plc (Ticker: GB:FAB), holds 17.18M shares in Oxford BioMedica (Ticker: OXBDF). Most recently, Timothy William Watts Bought ― shares of Shield Therapeutics on Feb 26, 2021 for an estimated value of 300.00K .

Timothy William Watts's Trading History

STX
Shield Therapeutics
Feb 26, 2021Chief Executive OfficerInformative Buy300.00K£52.46K
FAB
Fusion Antibodies Plc
Sep 25, 2018DirectorInformative Buy10.24K£1.17K
OXBDF
Oxford BioMedica
Sep 19, 2017Chief Financial Officer & Company SecretaryUninformative Sell―$119.59M

You May Also Like

Timothy William Watts insider profile FAQ

What is the percentage of profitable transactions made by Timothy William Watts?
The percentage of profitable transactions made by Timothy William Watts is 20%.
What is the average return per transaction made by Timothy William Watts?
The average return per transaction made by Timothy William Watts is -63.00%.
What stocks does Timothy William Watts hold?
Timothy William Watts holds: GB:STX, OXBDF, GB:FAB stocks.
What was Timothy William Watts’s latest transaction?
Timothy William Watts’s latest transaction was an Informative Buy of 300.00K .
What was Timothy William Watts's most profitable transaction?
Timothy William Watts’s most profitable transaction was an Informative Buy of OXBDF stock on June 16, 2014. The return on the trade was 212.50%.
What is Timothy William Watts's role in Shield Therapeutics?
Timothy William Watts's role in Shield Therapeutics is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.